Any feedback?
BRENDA home
Organism related
TaxTree of Organism Cricetulus griseus
Condensed Tree View
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
topPlease wait a moment until the data is sorted. This message will disappear when the data is sorted.
EC NUMBER 
COMMENTARY 
-
preliminary BRENDA-supplied EC number
preliminary BRENDA-supplied EC number
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
PATHWAY
BRENDA Link
KEGG Link
MetaCyc Link
(1'S,5'S)-averufin biosynthesis
-
-
PWY-5954
(4Z,7Z,10Z,13Z,16Z)-docosapentaenoate biosynthesis (6-desaturase)
-
-
PWY-7726
(5Z)-dodecenoate biosynthesis II
-
-
PWY-7858
(8E,10E)-dodeca-8,10-dienol biosynthesis
-
-
PWY-7654
(aminomethyl)phosphonate degradation
-
-
PWY-7805
(Kdo)2-lipid A biosynthesis (E. coli)
-
-
KDO-LIPASYN-PWY
(Kdo)2-lipid A biosynthesis (generic)
-
-
PWY-8285
(Kdo)2-lipid A biosynthesis (H. pylori)
-
-
PWY2DNV-2
(Kdo)2-lipid A biosynthesis (P. gingivalis)
-
-
PWY-8247
(Kdo)2-lipid A biosynthesis (P. putida)
-
-
PWY-8075
(Kdo)2-lipid A biosynthesis I (Brucella)
-
-
PWY2B4Q-7
(R)- and (S)-3-hydroxybutanoate biosynthesis (engineered)
-
-
PWY-7216
(R)-cysteate degradation
-
-
PWY-6642
(R,R)-butanediol biosynthesis
-
-
PWY-5951
(R,R)-butanediol degradation
-
-
PWY3O-246
(S)-lactate fermentation to propanoate, acetate and hydrogen
-
-
PWY-8086
(S)-propane-1,2-diol degradation
-
-
PWY-7013
(S)-reticuline biosynthesis I
-
-
PWY-3581
(S)-reticuline biosynthesis II
-
-
PWY-6133
1,2-dichloroethane degradation
-
-
12DICHLORETHDEG-PWY
1,3-propanediol biosynthesis (engineered)
-
-
PWY-7385
1,5-anhydrofructose degradation
-
-
PWY-6992
1-butanol autotrophic biosynthesis (engineered)
-
-
PWY-6886
1-methylpyrrolinium biosynthesis
-
-
PWY-5315
10-cis-heptadecenoyl-CoA degradation (yeast)
-
-
PWY-7337
10-trans-heptadecenoyl-CoA degradation (MFE-dependent, yeast)
-
-
PWY-7339
10-trans-heptadecenoyl-CoA degradation (reductase-dependent, yeast)
-
-
PWY-7338
11-oxyandrogens biosynthesis
-
-
PWY-8202
15-epi-lipoxin biosynthesis
-
-
PWY66-393
1D-myo-inositol hexakisphosphate biosynthesis I (from Ins(1,4,5)P3)
-
-
PWY-6361
1D-myo-inositol hexakisphosphate biosynthesis II (mammalian)
-
-
PWY-6362
1D-myo-inositol hexakisphosphate biosynthesis III (Spirodela polyrrhiza)
-
-
PWY-4661
1D-myo-inositol hexakisphosphate biosynthesis IV (Dictyostelium)
-
-
PWY-6372
1D-myo-inositol hexakisphosphate biosynthesis V (from Ins(1,3,4)P3)
-
-
PWY-6554
2'-deoxymugineic acid phytosiderophore biosynthesis
-
-
PWY-5912
2,3-dihydroxybenzoate biosynthesis
-
-
PWY-5901
2,4-dinitrotoluene degradation
-
-
PWY-5642
2-arachidonoylglycerol biosynthesis
-
-
PWY-8052
2-carboxy-1,4-naphthoquinol biosynthesis
-
-
PWY-5837
2-deoxy-D-glucose 6-phosphate degradation
-
-
PWY-8121
2-deoxy-D-ribose degradation II
-
-
PWY-8058
2-methyl-branched fatty acid beta-oxidation
-
-
PWY-8181
2-methylpropene degradation
-
-
PWY-7778
2-nitrotoluene degradation
-
-
PWY-5641
2-oxobutanoate degradation II
-
-
2OXOBUTYRATECAT-PWY
2-oxoglutarate decarboxylation to succinyl-CoA
-
-
PWY-5084
2-oxoisovalerate decarboxylation to isobutanoyl-CoA
-
-
PWY-5046
24-epi-campesterol, fucosterol, and clionasterol biosynthesis (diatoms)
-
-
PWY-8238
3,5-dimethoxytoluene biosynthesis
-
-
PWY-7076
3,8-divinyl-chlorophyllide a biosynthesis I (aerobic, light-dependent)
-
-
CHLOROPHYLL-SYN
3,8-divinyl-chlorophyllide a biosynthesis II (anaerobic)
-
-
PWY-5531
3,8-divinyl-chlorophyllide a biosynthesis III (aerobic, light independent)
-
-
PWY-7159
3-(4-hydroxyphenyl)pyruvate biosynthesis
-
-
PWY-5886
3-dehydroquinate biosynthesis II (archaea)
-
-
PWY-6160
3-hydroxy-4-methyl-anthranilate biosynthesis I
-
-
PWY-7717
3-hydroxy-4-methyl-anthranilate biosynthesis II
-
-
PWY-7765
3-hydroxypropanoate cycle
-
-
PWY-5743
3-hydroxypropanoate/4-hydroxybutanate cycle
-
-
PWY-5789
3-methyl-branched fatty acid alpha-oxidation
-
-
PWY66-387
3-methylbutanol biosynthesis (engineered)
-
-
PWY-6871
3-phenylpropanoate degradation
-
-
P281-PWY
3-phosphoinositide biosynthesis
-
-
PWY-6352
3-phosphoinositide degradation
-
-
PWY-6368
4-amino-2-methyl-5-diphosphomethylpyrimidine biosynthesis II
-
-
PWY-7282
4-aminobutanoate degradation V
-
-
PWY-5022
4-ethylphenol degradation (anaerobic)
-
-
PWY-6080
4-hydroxy-2-nonenal detoxification
-
-
PWY-7112
4-hydroxybenzoate biosynthesis I (eukaryotes)
-
-
PWY-5754
4-hydroxybenzoate biosynthesis III (plants)
-
-
PWY-6435
4-nitrophenol degradation I
-
-
PWY-5487
4-oxopentanoate degradation
-
-
PWY-7948
5'-deoxyadenosine degradation I
-
-
PWY-8130
5-aminoimidazole ribonucleotide biosynthesis I
-
-
PWY-6121
5-aminoimidazole ribonucleotide biosynthesis II
-
-
PWY-6122
5-oxo-L-proline metabolism
-
-
PWY-7942
6-gingerol analog biosynthesis (engineered)
-
-
PWY-6920
6-hydroxymethyl-dihydropterin diphosphate biosynthesis
-
-
6-hydroxymethyl-dihydropterin diphosphate biosynthesis I
-
-
PWY-6147
6-hydroxymethyl-dihydropterin diphosphate biosynthesis IV (Plasmodium)
-
-
PWY-7852
8-oxo-(d)GTP detoxification I
-
-
PWY-6502
9-cis, 11-trans-octadecadienoyl-CoA degradation (isomerase-dependent, yeast)
-
-
PWY-7340
ABH and Lewis epitopes biosynthesis from type 1 precursor disaccharide
-
-
PWY-7832
ABH and Lewis epitopes biosynthesis from type 2 precursor disaccharide
-
-
PWY-7831
Ac/N-end rule pathway
-
-
PWY-7800
acetaldehyde biosynthesis I
-
-
PWY-6333
acetaldehyde biosynthesis II
-
-
PWY-6330
acetate and ATP formation from acetyl-CoA III
-
-
PWY-8328
acetate conversion to acetyl-CoA
-
-
PWY0-1313
acetoacetate degradation (to acetyl CoA)
-
-
ACETOACETATE-DEG-PWY
acetone degradation I (to methylglyoxal)
-
-
PWY-5451
acetone degradation III (to propane-1,2-diol)
-
-
PWY-7466
acetyl-CoA biosynthesis from citrate
-
-
PWY-5172
acetyl-CoA fermentation to butanoate
-
-
PWY-5676
acetylene degradation (anaerobic)
-
-
P161-PWY
acrylonitrile degradation I
-
-
PWY-7308
acyl-CoA hydrolysis
-
-
PWY-5148
adenine and adenosine salvage I
-
-
P121-PWY
adenine and adenosine salvage II
-
-
PWY-6605
adenine and adenosine salvage III
-
-
PWY-6609
adenine and adenosine salvage V
-
-
PWY-6611
adenine and adenosine salvage VI
-
-
PWY-6619
adenine salvage
-
-
PWY-6610
adenosine deoxyribonucleotides de novo biosynthesis I
-
-
PWY-7227
adenosine deoxyribonucleotides de novo biosynthesis II
-
-
PWY-7220
adenosine nucleotides degradation I
-
-
PWY-6596
adenosine nucleotides degradation II
-
-
SALVADEHYPOX-PWY
adenosine ribonucleotides de novo biosynthesis
-
-
PWY-7219
adipate biosynthesis
-
-
PWY-8347
adipate degradation
-
-
PWY-8354
adlupulone and adhumulone biosynthesis
-
-
PWY-7857
aerobic respiration I (cytochrome c)
-
-
PWY-3781
aerobic respiration II (cytochrome c) (yeast)
-
-
PWY-7279
aerobic respiration III (alternative oxidase pathway)
-
-
PWY-4302
agarose degradation
-
-
PWY-6816
alkane oxidation
-
-
PWY-2724
all-trans-farnesol biosynthesis
-
-
PWY-6859
allantoin degradation to glyoxylate I
-
-
PWY-5694
allantoin degradation to glyoxylate III
-
-
PWY-5705
alliin metabolism
-
-
PWY-5706
allopregnanolone biosynthesis
-
-
PWY-7455
alpha-linolenate metabolites biosynthesis
-
-
PWY-8398
alpha-tomatine degradation
-
-
PWY18C3-5
Amaryllidacea alkaloids biosynthesis
-
-
PWY-7826
ammonia assimilation cycle I
-
-
PWY-6963
ammonia assimilation cycle II
-
-
PWY-6964
ammonia assimilation cycle III
-
-
AMMASSIM-PWY
ammonia oxidation II (anaerobic)
-
-
P303-PWY
amygdalin and prunasin degradation
-
-
PWY-6011
anaerobic energy metabolism (invertebrates, cytosol)
-
-
PWY-7383
anaerobic energy metabolism (invertebrates, mitochondrial)
-
-
PWY-7384
anandamide biosynthesis I
-
-
PWY-8051
anandamide biosynthesis II
-
-
PWY-8053
anandamide degradation
-
-
PWY6666-1
anandamide lipoxygenation
-
-
PWY-8056
androgen biosynthesis
-
-
PWY66-378
androstenedione degradation I (aerobic)
-
-
PWY-6944
androstenedione degradation II (anaerobic)
-
-
PWY-8152
anteiso-branched-chain fatty acid biosynthesis
-
-
PWY-8173
apratoxin A biosynthesis
-
-
PWY-8361
arachidonate biosynthesis I (6-desaturase, lower eukaryotes)
-
-
PWY-5353
arachidonate biosynthesis IV (8-detaturase, lower eukaryotes)
-
-
PWY-7601
arachidonate metabolites biosynthesis
-
-
PWY-8397
Arg/N-end rule pathway (eukaryotic)
-
-
PWY-7799
arginine dependent acid resistance
-
-
PWY0-1299
aromatic glucosinolate activation
-
-
PWY-6684
aromatic biogenic amine degradation (bacteria)
-
-
PWY-7431
arsenate detoxification I
-
-
PWY-8264
arsenic detoxification (mammals)
-
-
PWY-4202
arsenic detoxification (plants)
-
-
PWY-8259
arsenic detoxification (yeast)
-
-
PWY-4621
arsenite to oxygen electron transfer
-
-
PWY-4521
arsenite to oxygen electron transfer (via azurin)
-
-
PWY-7429
ascorbate glutathione cycle
-
-
PWY-2261
ascorbate recycling (cytosolic)
-
-
PWY-6370
aspirin triggered resolvin D biosynthesis
-
-
PWY66-395
aspirin triggered resolvin E biosynthesis
-
-
PWY66-394
assimilatory sulfate reduction II
-
-
SULFMETII-PWY
assimilatory sulfate reduction III
-
-
PWY-6683
assimilatory sulfate reduction IV
-
-
PWY1ZNC-1
astaxanthin biosynthesis (bacteria, fungi, algae)
-
-
PWY-5288
ATP biosynthesis
-
-
PWY-7980
atromentin biosynthesis
-
-
PWY-7518
backdoor pathway of androgen biosynthesis
-
-
PWY-8200
bacterial bioluminescence
-
-
PWY-7723
baicalein degradation (hydrogen peroxide detoxification)
-
-
PWY-7214
benzoate biosynthesis I (CoA-dependent, beta-oxidative)
-
-
PWY-6443
benzoyl-CoA biosynthesis
-
-
PWY-6458
beta-(1,4)-mannan degradation
-
-
PWY-7456
beta-1,4-D-mannosyl-N-acetyl-D-glucosamine degradation
-
-
PWY-7586
beta-alanine biosynthesis I
-
-
PWY-3981
beta-alanine biosynthesis IV
-
-
PWY-5760
beta-carboline biosynthesis
-
-
PWY-5877
beta-D-glucuronide and D-glucuronate degradation
-
-
PWY-7247
betalamic acid biosynthesis
-
-
PWY-5394
betanidin degradation
-
-
PWY-5461
betaxanthin biosynthesis
-
-
PWY-5426
betaxanthin biosynthesis (via dopamine)
-
-
PWY-5403
Bifidobacterium shunt
-
-
P124-PWY
bile acid biosynthesis, neutral pathway
biosynthesis of Lewis epitopes (H. pylori)
-
-
PWY-7833
biotin-carboxyl carrier protein assembly
-
-
PWY0-1264
bisabolene biosynthesis (engineered)
-
-
PWY-7102
brassinolide biosynthesis I
-
-
PWY-699
brassinolide biosynthesis II
-
-
PWY-2582
bryostatin biosynthesis
-
-
PWY-8047
bupropion degradation
-
-
PWY66-241
butanol and isobutanol biosynthesis (engineered)
-
-
PWY-7396
C20 prostanoid biosynthesis
-
-
PWY66-374
C25,25 CDP-archaeol biosynthesis
-
-
PWY-8365
C4 photosynthetic carbon assimilation cycle, NAD-ME type
-
-
PWY-7115
C4 photosynthetic carbon assimilation cycle, NADP-ME type
-
-
PWY-241
C4 photosynthetic carbon assimilation cycle, PEPCK type
-
-
PWY-7117
caffeine biosynthesis I
-
-
PWY-5037
caffeine biosynthesis II (via paraxanthine)
-
-
PWY-5038
caffeine degradation III (bacteria, via demethylation)
-
-
PWY-6538
Calvin-Benson-Bassham cycle
-
-
CALVIN-PWY
camalexin biosynthesis
-
-
CAMALEXIN-SYN
canavanine biosynthesis
-
-
PWY-5
canavanine degradation
-
-
PWY-31
cardiolipin and phosphatidylethanolamine biosynthesis (Xanthomonas)
-
-
PWY-7509
cardiolipin biosynthesis I
-
-
PWY-5668
cardiolipin biosynthesis II
-
-
PWY-5269
cardiolipin biosynthesis III
-
-
PWY0-1545
catechol degradation to 2-hydroxypentadienoate I
-
-
P183-PWY
catechol degradation to 2-hydroxypentadienoate II
-
-
PWY-5419
catecholamine biosynthesis
CDP-6-deoxy-D-gulose biosynthesis
-
-
PWY-8139
CDP-diacylglycerol biosynthesis I
-
-
PWY-5667
CDP-diacylglycerol biosynthesis II
-
-
PWY0-1319
CDP-diacylglycerol biosynthesis III
-
-
PWY-5981
cell-surface glycoconjugate-linked phosphocholine biosynthesis
-
-
PWY-7886
cellulose degradation II (fungi)
-
-
PWY-6788
ceramide and sphingolipid recycling and degradation (yeast)
-
-
PWY-7119
ceramide de novo biosynthesis
-
-
PWY3DJ-12
ceramide degradation (generic)
-
-
PWY-6483
ceramide degradation by alpha-oxidation
-
-
PWY66-388
chitin biosynthesis
-
-
PWY-6981
chitin deacetylation
-
-
PWY-7118
chitin degradation I (archaea)
-
-
PWY-6855
chitin degradation II (Vibrio)
-
-
PWY-6902
chitin degradation III (Serratia)
-
-
PWY-7822
chlorogenic acid degradation
-
-
PWY-6781
chlorpyrifos degradation
-
-
PWY-8065
cholesterol biosynthesis (algae, late side-chain reductase)
-
-
PWY-8191
cholesterol biosynthesis (diatoms)
-
-
PWY-8239
cholesterol biosynthesis (plants, early side-chain reductase)
-
-
PWY18C3-1
cholesterol biosynthesis I
-
-
PWY66-341
cholesterol biosynthesis II (via 24,25-dihydrolanosterol)
-
-
PWY66-3
cholesterol biosynthesis III (via desmosterol)
-
-
PWY66-4
cholesterol degradation to androstenedione I (cholesterol oxidase)
-
-
PWY-6945
cholesterol degradation to androstenedione II (cholesterol dehydrogenase)
-
-
PWY-6946
cholesterol degradation to androstenedione III (anaerobic)
-
-
PWY-8151
choline biosynthesis III
-
-
PWY-3561
chondroitin biosynthesis
-
-
PWY-6566
chondroitin sulfate degradation I (bacterial)
-
-
PWY-6572
chorismate biosynthesis from 3-dehydroquinate
-
-
PWY-6163
cis-geranyl-CoA degradation
-
-
PWY-6672
cis-zeatin biosynthesis
-
-
PWY-2781
CMP phosphorylation
-
-
PWY-7205
CMP-legionaminate biosynthesis I
-
-
PWY-6749
CMP-N-acetylneuraminate biosynthesis I (eukaryotes)
-
-
PWY-6138
CMP-N-acetylneuraminate biosynthesis II (bacteria)
-
-
PWY-6139
CMP-N-glycoloylneuraminate biosynthesis
-
-
PWY-6144
CO2 fixation into oxaloacetate (anaplerotic)
-
-
PWYQT-4429
coenzyme B biosynthesis
-
-
P241-PWY
coenzyme M biosynthesis II
-
-
PWY-6643
colanic acid building blocks biosynthesis
-
-
COLANSYN-PWY
colupulone and cohumulone biosynthesis
-
-
PWY-5133
complex N-linked glycan biosynthesis (plants)
-
-
PWY-7920
complex N-linked glycan biosynthesis (vertebrates)
-
-
PWY-7426
coumarin biosynthesis (via 2-coumarate)
-
-
PWY-5176
creatine phosphate biosynthesis
-
-
PWY-6158
creatinine degradation I
-
-
CRNFORCAT-PWY
creatinine degradation II
-
-
PWY-4722
cremeomycin biosynthesis
-
-
PWY-8296
crotonate fermentation (to acetate and cyclohexane carboxylate)
-
-
PWY-7401
crotonyl-CoA/ethylmalonyl-CoA/hydroxybutyryl-CoA cycle (engineered)
-
-
PWY-7854
curacin A biosynthesis
-
-
PWY-8358
cutin biosynthesis
-
-
PWY-321
cyanate degradation
cytosolic NADPH production (yeast)
-
-
PWY-7268
D-arabinose degradation V
-
-
PWY-8334
D-cycloserine biosynthesis
-
-
PWY-7274
D-galactose degradation I (Leloir pathway)
-
-
PWY-6317
D-galactose degradation IV
-
-
PWY-6693
D-galactose detoxification
-
-
PWY-3821
D-mannose degradation I
-
-
MANNCAT-PWY
D-mannose degradation II
-
-
PWY3O-1743
D-myo-inositol (1,3,4)-trisphosphate biosynthesis
-
-
PWY-6364
D-myo-inositol (1,4,5)-trisphosphate biosynthesis
-
-
PWY-6351
D-myo-inositol (1,4,5)-trisphosphate degradation
-
-
PWY-6363
D-myo-inositol (1,4,5,6)-tetrakisphosphate biosynthesis
-
-
PWY-6366
D-myo-inositol-5-phosphate metabolism
-
-
PWY-6367
D-sorbitol biosynthesis I
-
-
PWY-5054
D-sorbitol degradation I
-
-
PWY-4101
D-xylose degradation IV
-
-
PWY-7294
D-xylose degradation to ethylene glycol (engineered)
-
-
PWY-7178
degradation of aromatic, nitrogen containing compounds
-
-
dermatan sulfate degradation I (bacterial)
-
-
PWY-7646
detoxification of reactive carbonyls in chloroplasts
-
-
PWY-6786
di-homo-gamma-linolenate metabolites biosynthesis
-
-
PWY-8396
diacylglycerol and triacylglycerol biosynthesis
-
-
TRIGLSYN-PWY
diacylglycerol biosynthesis (PUFA enrichment in oilseed)
-
-
PWY-6804
diethylphosphate degradation
-
-
PWY-5491
digitoxigenin biosynthesis
-
-
PWY-6032
dimethyl sulfide biosynthesis from methionine
-
-
PWY-7793
dimorphecolate biosynthesis
-
-
PWY-5368
diphthamide biosynthesis I (archaea)
-
-
PWY-6482
diphthamide biosynthesis II (eukaryotes)
-
-
PWY-7546
dipicolinate biosynthesis
-
-
PWY-8088
dissimilatory sulfate reduction I (to hydrogen sufide))
-
-
DISSULFRED-PWY
divinyl ether biosynthesis II
-
-
PWY-5409
docosahexaenoate biosynthesis I (lower eukaryotes)
-
-
PWY-7053
docosahexaenoate biosynthesis III (6-desaturase, mammals)
-
-
PWY-7606
docosahexaenoate metabolites biosynthesis
-
-
PWY-8400
dolichol and dolichyl phosphate biosynthesis
dopamine degradation
-
-
PWY6666-2
drosopterin and aurodrosopterin biosynthesis
-
-
PWY-7442
dTDP-4-O-demethyl-beta-L-noviose biosynthesis
-
-
PWY-7301
dTDP-beta-L-rhamnose biosynthesis
-
-
DTDPRHAMSYN-PWY
dTDP-L-daunosamine biosynthesis
-
-
PWY-7814
dTDP-sibirosamine biosynthesis
-
-
PWY-8380
dTMP de novo biosynthesis (mitochondrial)
-
-
PWY66-385
dZTP biosynthesis
-
-
PWY-8289
ectoine biosynthesis
-
-
P101-PWY
Entner-Doudoroff pathway I
-
-
PWY-8004
Entner-Doudoroff pathway II (non-phosphorylative)
-
-
NPGLUCAT-PWY
Entner-Doudoroff pathway III (semi-phosphorylative)
-
-
PWY-2221
epoxysqualene biosynthesis
-
-
PWY-5670
ergosterol biosynthesis II
-
-
PWY-7154
ergothioneine biosynthesis I (bacteria)
-
-
PWY-7255
erythritol biosynthesis I
-
-
PWY-8372
erythritol biosynthesis II
-
-
PWY-8373
erythro-tetrahydrobiopterin biosynthesis I
-
-
PWY-5663
Escherichia coli serotype O:127 O antigen biosynthesis
-
-
PWY-8231
Escherichia coli serotype O:1B/Salmonella enterica serotype O:42 O antigen biosynthesis
-
-
PWY-8237
Escherichia coli serotype O:85/Salmonella enterica serotype O:17 O antigen biosynthesis
-
-
PWY-8207
Escherichia coli serotype O:86 O antigen biosynthesis
-
-
PWY-7290
estradiol biosynthesis I (via estrone)
-
-
PWY66-380
ethanol degradation I
-
-
ETOH-ACETYLCOA-ANA-PWY
ethanol degradation II
-
-
PWY66-21
ethanol degradation III
-
-
PWY66-161
ethanol degradation IV
-
-
PWY66-162
ethanolamine utilization
-
-
PWY0-1477
ethene biosynthesis I (plants)
-
-
ETHYL-PWY
ethene biosynthesis II (microbes)
-
-
PWY-6853
ethene biosynthesis III (microbes)
-
-
PWY-6854
ethene biosynthesis IV (engineered)
-
-
PWY-7126
ethene biosynthesis V (engineered)
-
-
PWY-7124
ethylbenzene degradation (anaerobic)
-
-
PWY-481
ethylmalonyl-CoA pathway
-
-
PWY-5741
eumelanin biosynthesis
-
-
PWY-6498
even iso-branched-chain fatty acid biosynthesis
-
-
PWY-8175
farnesylcysteine salvage pathway
-
-
PWY-6577
fatty acid alpha-oxidation I (plants)
-
-
PWY-2501
fatty acid beta-oxidation I (generic)
-
-
FAO-PWY
fatty acid beta-oxidation II (plant peroxisome)
-
-
PWY-5136
fatty acid beta-oxidation V (unsaturated, odd number, di-isomerase-dependent)
-
-
PWY-6837
fatty acid beta-oxidation VI (mammalian peroxisome)
-
-
PWY66-391
fatty acid beta-oxidation VII (yeast peroxisome)
-
-
PWY-7288
fatty acid biosynthesis initiation (mitochondria)
-
-
PWY66-429
fatty acid biosynthesis initiation (plant mitochondria)
-
-
PWY-6799
fatty acid biosynthesis initiation (type II)
-
-
PWY-4381
fatty acid salvage
-
-
PWY-7094
Fe(II) oxidation
-
-
PWY-6692
FeMo cofactor biosynthesis
-
-
PWY-7710
ferrichrome A biosynthesis
-
-
PWY-7571
firefly bioluminescence
-
-
PWY-7913
flavin biosynthesis I (bacteria and plants)
-
-
RIBOSYN2-PWY
flavin biosynthesis II (archaea)
-
-
PWY-6167
flavin biosynthesis III (fungi)
-
-
PWY-6168
flexixanthin biosynthesis
-
-
PWY-7947
fluoroacetate and fluorothreonine biosynthesis
-
-
PWY-6644
folate polyglutamylation
folate transformations I
-
-
PWY-2201
folate transformations II (plants)
-
-
PWY-3841
folate transformations III (E. coli)
-
-
1CMET2-PWY
formaldehyde assimilation I (serine pathway)
-
-
PWY-1622
formaldehyde assimilation II (assimilatory RuMP Cycle)
-
-
PWY-1861
formaldehyde assimilation III (dihydroxyacetone cycle)
-
-
P185-PWY
formaldehyde oxidation I
-
-
RUMP-PWY
formaldehyde oxidation II (glutathione-dependent)
-
-
PWY-1801
formaldehyde oxidation VII (THF pathway)
-
-
PWY-7909
formate assimilation into 5,10-methylenetetrahydrofolate
-
-
PWY-1722
fructose 2,6-bisphosphate biosynthesis
-
-
PWY66-423
GABA shunt I
-
-
GLUDEG-I-PWY
GABA shunt II
-
-
PWY-8346
gala-series glycosphingolipids biosynthesis
-
-
PWY-7840
gamma-glutamyl cycle
-
-
PWY-4041
gamma-linolenate biosynthesis II (animals)
-
-
PWY-6000
ganglio-series glycosphingolipids biosynthesis
-
-
PWY-7836
GDP-6-deoxy-D-talose biosynthesis
-
-
PWY-5738
GDP-alpha-D-glucose biosynthesis
-
-
PWY-5661
GDP-D-perosamine biosynthesis
-
-
PWY-5739
GDP-D-rhamnose biosynthesis
-
-
GDPRHAMSYN-PWY
GDP-L-colitose biosynthesis
-
-
PWY-5740
GDP-L-fucose biosynthesis I (from GDP-D-mannose)
-
-
PWY-66
GDP-L-fucose biosynthesis II (from L-fucose)
-
-
PWY-6
GDP-mannose biosynthesis
-
-
PWY-5659
GDP-mycosamine biosynthesis
-
-
PWY-7573
GDP-N-acetyl-alpha-D-perosamine biosynthesis
-
-
PWY-8225
GDP-N-formyl-alpha-D-perosamine biosynthesis
-
-
PWY2B4Q-2
gliotoxin biosynthesis
-
-
PWY-7533
globo-series glycosphingolipids biosynthesis
-
-
PWY-7838
glucocorticoid biosynthesis
-
-
PWY66-381
gluconeogenesis I
-
-
GLUCONEO-PWY
gluconeogenesis II (Methanobacterium thermoautotrophicum)
-
-
PWY-6142
gluconeogenesis III
-
-
PWY66-399
glucose and glucose-1-phosphate degradation
-
-
GLUCOSE1PMETAB-PWY
glucose degradation (oxidative)
-
-
DHGLUCONATE-PYR-CAT-PWY
glucosinolate activation
-
-
PWY-5267
glucosylglycerol biosynthesis
-
-
PWY-7902
glutamate removal from folates
-
-
PWY-2161B
glutaminyl-tRNAgln biosynthesis via transamidation
-
-
PWY-5921
glutaryl-CoA degradation
-
-
PWY-5177
glutathione biosynthesis
-
-
GLUTATHIONESYN-PWY
glutathione degradation (DUG pathway)
-
-
PWY-7559
glutathione-mediated detoxification I
-
-
PWY-4061
glutathione-mediated detoxification II
-
-
PWY-6842
glutathione-peroxide redox reactions
-
-
PWY-4081
glycerol degradation I
-
-
PWY-4261
glycerol degradation to butanol
-
-
PWY-7003
glycerol-3-phosphate shuttle
-
-
PWY-6118
glycerol-3-phosphate to cytochrome bo oxidase electron transfer
-
-
PWY0-1561
glycerol-3-phosphate to fumarate electron transfer
-
-
PWY0-1582
glycerol-3-phosphate to hydrogen peroxide electron transport
-
-
PWY0-1591
glycerophosphodiester degradation
-
-
PWY-6952
glycine betaine biosynthesis IV (from glycine)
-
-
P541-PWY
glycine betaine biosynthesis V (from glycine)
-
-
PWY-6004
glycine betaine degradation I
-
-
PWY-3661
glycine betaine degradation II (mammalian)
-
-
PWY-3661-1
glycine betaine degradation III
-
-
PWY-8325
glycine biosynthesis I
-
-
GLYSYN-PWY
glycine biosynthesis II
-
-
GLYCINE-SYN2-PWY
glycine cleavage
-
-
GLYCLEAV-PWY
glycogen biosynthesis I (from ADP-D-Glucose)
-
-
GLYCOGENSYNTH-PWY
glycogen biosynthesis II (from UDP-D-Glucose)
-
-
PWY-5067
glycogen biosynthesis III (from alpha-maltose 1-phosphate)
-
-
PWY-7900
glycogen degradation I
-
-
GLYCOCAT-PWY
glycogen degradation II
-
-
PWY-5941
glycogen degradation III (via anhydrofructose)
-
-
PWY-7662
glycolysis I (from glucose 6-phosphate)
-
-
GLYCOLYSIS
glycolysis II (from fructose 6-phosphate)
-
-
PWY-5484
glycolysis III (from glucose)
-
-
ANAGLYCOLYSIS-PWY
glycolysis IV
-
-
PWY-1042
glycolysis V (Pyrococcus)
-
-
P341-PWY
glycosaminoglycan-protein linkage region biosynthesis
-
-
PWY-6557
glyoxylate assimilation
-
-
PWY-5744
glyoxylate cycle
-
-
GLYOXYLATE-BYPASS
glyphosate degradation III
-
-
PWY-7807
gossypol biosynthesis
-
-
PWY-5773
grixazone biosynthesis
-
-
PWY-7153
guaiacol biosynthesis
-
-
PWY18C3-23
guanine and guanosine salvage I
-
-
PWY-6620
guanine and guanosine salvage II
-
-
PWY-6599
guanine and guanosine salvage III
-
-
PWY-6618
guanosine deoxyribonucleotides de novo biosynthesis I
-
-
PWY-7226
guanosine deoxyribonucleotides de novo biosynthesis II
-
-
PWY-7222
guanosine nucleotides degradation I
-
-
PWY-6607
guanosine nucleotides degradation II
-
-
PWY-6606
guanosine nucleotides degradation III
-
-
PWY-6608
guanosine ribonucleotides de novo biosynthesis
-
-
PWY-7221
H. pylori 26695 O-antigen biosynthesis
-
-
PWY2DNV-5
heme b biosynthesis I (aerobic)
-
-
HEME-BIOSYNTHESIS-II
heme b biosynthesis II (oxygen-independent)
-
-
HEMESYN2-PWY
heme b biosynthesis IV (Gram-positive bacteria)
-
-
PWY-7766
heme b biosynthesis V (aerobic)
-
-
HEME-BIOSYNTHESIS-II-1
heme degradation I
-
-
PWY-5874
heparan sulfate biosynthesis
-
-
PWY-6558
heparan sulfate degradation
-
-
PWY-7651
heparin degradation
-
-
PWY-7644
heterolactic fermentation
-
-
P122-PWY
histamine biosynthesis
-
-
PWY-6173
histamine degradation
-
-
PWY-6181
homocysteine and cysteine interconversion
-
-
PWY-801
homoglutathione biosynthesis
-
-
PWY-6840
homospermidine biosynthesis I
-
-
PWY-5907
homospermidine biosynthesis II
-
-
PWY-8149
hyaluronan degradation
-
-
PWY-7645
hydrogen sulfide biosynthesis II (mammalian)
-
-
PWY66-426
hydrogen to fumarate electron transfer
-
-
PWY0-1576
hydroxycinnamic acid serotonin amides biosynthesis
-
-
PWY-5473
hydroxycinnamic acid tyramine amides biosynthesis
-
-
PWY-5474
hydroxylated fatty acid biosynthesis (plants)
-
-
PWY-6433
hypoglycin biosynthesis
-
-
PWY-5826
hypotaurine degradation
-
-
PWY-7387
hypusine biosynthesis
-
-
PWY-5905
i antigen and I antigen biosynthesis
-
-
PWY-7837
icosapentaenoate biosynthesis I (lower eukaryotes)
-
-
PWY-6958
icosapentaenoate biosynthesis II (6-desaturase, mammals)
-
-
PWY-7049
icosapentaenoate biosynthesis V (8-desaturase, lower eukaryotes)
-
-
PWY-7602
icosapentaenoate metabolites biosynthesis
-
-
PWY-8399
incomplete reductive TCA cycle
-
-
P42-PWY
indole glucosinolate activation (herbivore attack)
-
-
PWYQT-4476
indole glucosinolate activation (intact plant cell)
-
-
PWYQT-4477
indole-3-acetate biosynthesis II
-
-
PWY-581
indole-3-acetate biosynthesis III (bacteria)
-
-
PWY-3161
indole-3-acetate biosynthesis IV (bacteria)
-
-
PWY-5025
indole-3-acetate biosynthesis VI (bacteria)
-
-
TRPIAACAT-PWY
inosine 5'-phosphate degradation
-
-
PWY-5695
inosine-5'-phosphate biosynthesis I
-
-
PWY-6123
inosine-5'-phosphate biosynthesis II
-
-
PWY-6124
inosine-5'-phosphate biosynthesis III
-
-
PWY-7234
inositol diphosphates biosynthesis
-
-
PWY-6369
inulin degradation
-
-
PWY-8314
isoprene biosynthesis II (engineered)
-
-
PWY-7391
isopropanol biosynthesis (engineered)
-
-
PWY-6876
itaconate degradation
-
-
PWY-5749
jasmonic acid biosynthesis
-
-
PWY-735
justicidin B biosynthesis
-
-
PWY-6824
juvenile hormone III biosynthesis II
-
-
PWY-6650
Kdo-lipid A biosynthesis (Vibrio cholerae serogroup O1 El Tor)
-
-
PWY-8378
ketogenesis
-
-
PWY66-367
ketolysis
-
-
PWY66-368
L-alanine biosynthesis I
-
-
ALANINE-VALINESYN-PWY
L-alanine biosynthesis II
-
-
ALANINE-SYN2-PWY
L-alanine degradation II (to D-lactate)
-
-
ALACAT2-PWY
L-alanine degradation III
-
-
ALANINE-DEG3-PWY
L-alanine degradation V (oxidative Stickland reaction)
-
-
PWY-8189
L-alanine degradation VI (reductive Stickland reaction)
-
-
PWY-8188
L-arabinose degradation II
-
-
PWY-5515
L-arabinose degradation IV
-
-
PWY-7295
L-arginine biosynthesis I (via L-ornithine)
-
-
ARGSYN-PWY
L-arginine biosynthesis II (acetyl cycle)
-
-
ARGSYNBSUB-PWY
L-arginine biosynthesis III (via N-acetyl-L-citrulline)
-
-
PWY-5154
L-arginine biosynthesis IV (archaea)
-
-
PWY-7400
L-arginine degradation I (arginase pathway)
-
-
ARGASEDEG-PWY
L-arginine degradation II (AST pathway)
-
-
AST-PWY
L-arginine degradation III (arginine decarboxylase/agmatinase pathway)
-
-
PWY0-823
L-arginine degradation IV (arginine decarboxylase/agmatine deiminase pathway)
-
-
ARGDEG-III-PWY
L-arginine degradation VI (arginase 2 pathway)
-
-
ARG-PRO-PWY
L-arginine degradation VII (arginase 3 pathway)
-
-
ARG-GLU-PWY
L-arginine degradation X (arginine monooxygenase pathway)
-
-
ARGDEG-V-PWY
L-arginine degradation XIII (reductive Stickland reaction)
-
-
PWY-8187
L-arginine degradation XIV (oxidative Stickland reaction)
-
-
PWY-6344
L-ascorbate degradation I (bacterial, anaerobic)
-
-
PWY0-301
L-asparagine biosynthesis I
-
-
ASPARAGINE-BIOSYNTHESIS
L-asparagine biosynthesis II
-
-
ASPARAGINESYN-PWY
L-asparagine biosynthesis III (tRNA-dependent)
-
-
PWY490-4
L-asparagine degradation I
-
-
ASPARAGINE-DEG1-PWY
L-asparagine degradation III (mammalian)
-
-
ASPARAGINE-DEG1-PWY-1
L-aspartate biosynthesis
-
-
ASPARTATESYN-PWY
L-aspartate degradation I
-
-
ASPARTATE-DEG1-PWY
L-aspartate degradation II (aerobic)
-
-
PWY-8291
L-aspartate degradation III (anaerobic)
-
-
PWY-8294
L-carnitine degradation II
-
-
PWY-3641
L-citrulline biosynthesis
-
-
CITRULBIO-PWY
L-citrulline degradation
-
-
CITRULLINE-DEG-PWY
L-cysteine biosynthesis I
-
-
CYSTSYN-PWY
L-cysteine biosynthesis III (from L-homocysteine)
-
-
HOMOCYSDEGR-PWY
L-cysteine biosynthesis VI (reverse transsulfuration)
-
-
PWY-I9
L-cysteine biosynthesis VII (from S-sulfo-L-cysteine)
-
-
PWY-7870
L-dopa and L-dopachrome biosynthesis
-
-
PWY-6481
L-dopa degradation I (mammalian)
-
-
PWY-6334
L-dopa degradation II (bacterial)
-
-
PWY-8110
L-glutamate biosynthesis I
-
-
GLUTSYN-PWY
L-glutamate biosynthesis II
-
-
GLUTAMATE-SYN2-PWY
L-glutamate degradation I
-
-
GLUTAMATE-DEG1-PWY
L-glutamate degradation II
-
-
GLUTDEG-PWY
L-glutamate degradation IX (via 4-aminobutanoate)
-
-
PWY0-1305
L-glutamate degradation V (via hydroxyglutarate)
-
-
P162-PWY
L-glutamate degradation VI (to pyruvate)
-
-
PWY-5087
L-glutamate degradation X
-
-
PWY-5766
L-glutamate degradation XI (reductive Stickland reaction)
-
-
PWY-8190
L-glutamine biosynthesis I
-
-
GLNSYN-PWY
L-glutamine degradation I
-
-
GLUTAMINDEG-PWY
L-histidine degradation I
-
-
HISDEG-PWY
L-histidine degradation II
-
-
PWY-5028
L-histidine degradation III
-
-
PWY-5030
L-histidine degradation V
-
-
PWY-5031
L-histidine degradation VI
-
-
HISHP-PWY
L-homoserine biosynthesis
-
-
HOMOSERSYN-PWY
L-isoleucine biosynthesis I (from threonine)
-
-
ILEUSYN-PWY
L-isoleucine biosynthesis II
-
-
PWY-5101
L-isoleucine biosynthesis III
-
-
PWY-5103
L-isoleucine biosynthesis IV
-
-
PWY-5104
L-isoleucine biosynthesis V
-
-
PWY-5108
L-isoleucine degradation I
-
-
ILEUDEG-PWY
L-isoleucine degradation II
-
-
PWY-5078
L-isoleucine degradation III (oxidative Stickland reaction)
-
-
PWY-8184
L-leucine biosynthesis
-
-
LEUSYN-PWY
L-leucine degradation I
-
-
LEU-DEG2-PWY
L-leucine degradation III
-
-
PWY-5076
L-leucine degradation IV (reductive Stickland reaction)
-
-
PWY-7767
L-leucine degradation V (oxidative Stickland reaction)
-
-
PWY-8185
L-lysine biosynthesis I
-
-
DAPLYSINESYN-PWY
L-lysine biosynthesis II
-
-
PWY-2941
L-lysine biosynthesis III
-
-
PWY-2942
L-lysine biosynthesis IV
-
-
LYSINE-AMINOAD-PWY
L-lysine biosynthesis V
-
-
PWY-3081
L-lysine biosynthesis VI
-
-
PWY-5097
L-lysine degradation V
-
-
PWY-5283
L-lysine degradation XI
-
-
LYSINE-DEG1-PWY
L-lysine fermentation to acetate and butanoate
-
-
P163-PWY
L-malate degradation II
-
-
PWY-7686
L-methionine biosynthesis IV
-
-
PWY-7977
L-methionine degradation I (to L-homocysteine)
-
-
METHIONINE-DEG1-PWY
L-methionine degradation III
-
-
PWY-5082
L-methionine salvage from L-homocysteine
-
-
ADENOSYLHOMOCYSCAT-PWY
L-Ndelta-acetylornithine biosynthesis
-
-
PWY-6922
L-nicotianamine biosynthesis
-
-
PWY-5957
L-ornithine biosynthesis II
-
-
ARGININE-SYN4-PWY
L-phenylalanine biosynthesis I
-
-
PHESYN
L-phenylalanine degradation I (aerobic)
-
-
PHENYLALANINE-DEG1-PWY
L-phenylalanine degradation II (anaerobic)
-
-
ANAPHENOXI-PWY
L-phenylalanine degradation III
-
-
PWY-5079
L-phenylalanine degradation IV (mammalian, via side chain)
-
-
PWY-6318
L-phenylalanine degradation V
-
-
PWY-7158
L-phenylalanine degradation VI (reductive Stickland reaction)
-
-
PWY-8014
L-proline biosynthesis I (from L-glutamate)
-
-
PROSYN-PWY
L-proline biosynthesis III (from L-ornithine)
-
-
PWY-3341
L-proline degradation I
-
-
PROUT-PWY
L-selenocysteine biosynthesis I (bacteria)
-
-
PWY0-901
L-selenocysteine biosynthesis II (archaea and eukaryotes)
-
-
PWY-6281
L-serine biosynthesis I
-
-
SERSYN-PWY
L-serine biosynthesis II
-
-
PWY-8011
L-threonine degradation III (to methylglyoxal)
-
-
THRDLCTCAT-PWY
L-tryptophan degradation I (via anthranilate)
-
-
TRPCAT-PWY
L-tryptophan degradation IV (via indole-3-lactate)
-
-
TRPKYNCAT-PWY
L-tryptophan degradation to 2-amino-3-carboxymuconate semialdehyde
-
-
PWY-5651
L-tryptophan degradation V (side chain pathway)
-
-
PWY-3162
L-tryptophan degradation VI (via tryptamine)
-
-
PWY-3181
L-tryptophan degradation VIII (to tryptophol)
-
-
PWY-5081
L-tryptophan degradation X (mammalian, via tryptamine)
-
-
PWY-6307
L-tryptophan degradation XI (mammalian, via kynurenine)
-
-
PWY-6309
L-tryptophan degradation XIII (reductive Stickland reaction)
-
-
PWY-8017
L-tyrosine biosynthesis I
-
-
TYRSYN
L-tyrosine biosynthesis IV
-
-
PWY-6134
L-tyrosine degradation I
-
-
TYRFUMCAT-PWY
L-tyrosine degradation II
-
-
PWY-5151
L-tyrosine degradation III
-
-
PWY3O-4108
L-tyrosine degradation IV (to 4-methylphenol)
-
-
PWY-7514
L-tyrosine degradation V (reductive Stickland reaction)
-
-
PWY-8016
L-valine biosynthesis
-
-
VALSYN-PWY
L-valine degradation I
-
-
VALDEG-PWY
L-valine degradation II
-
-
PWY-5057
L-valine degradation III (oxidative Stickland reaction)
-
-
PWY-8183
lactate fermentation to acetate, CO2 and hydrogen (Desulfovibrionales)
-
-
PWY-8377
lacto-series glycosphingolipids biosynthesis
-
-
PWY-7839
lanosterol biosynthesis
-
-
PWY-6132
leukotriene biosynthesis
-
-
PWY66-375
limonene degradation IV (anaerobic)
-
-
PWY-8029
linamarin degradation
-
-
PWY-3121
linezolid resistance
-
-
PWY-6828
linoleate biosynthesis I (plants)
-
-
PWY-5995
linoleate metabolites biosynthesis
-
-
PWY-8395
linustatin bioactivation
-
-
PWY-7091
lipid A-core biosynthesis (E. coli K-12)
-
-
LIPA-CORESYN-PWY
lipid IVA biosynthesis (2,3-diamino-2,3-dideoxy-D-glucopyranose-containing)
-
-
PWY2B4Q-4
lipid IVA biosynthesis (E. coli)
-
-
NAGLIPASYN-PWY
lipid IVA biosynthesis (generic)
-
-
PWY-8283
lipid IVA biosynthesis (H. pylori)
-
-
PWYI-14
lipid IVA biosynthesis (P. gingivalis)
-
-
PWY-8245
lipid IVA biosynthesis (P. putida)
-
-
PWY-8073
lipid IVA biosynthesis (Vibrio cholerae serogroup O1 El Tor)
-
-
PWY2G6Z-2
lipoxin biosynthesis
-
-
PWY66-392
long chain fatty acid ester synthesis (engineered)
-
-
PWY-6873
lotaustralin degradation
-
-
PWY-6002
lupulone and humulone biosynthesis
-
-
PWY-5132
luteolin triglucuronide degradation
-
-
PWY-7445
malate/L-aspartate shuttle pathway
-
-
MALATE-ASPARTATE-SHUTTLE-PWY
manganese oxidation I
-
-
PWY-6591
mannitol biosynthesis
-
-
PWY-3881
mannitol cycle
-
-
PWY-6531
mannitol degradation II
-
-
PWY-3861
maresin biosynthesis
-
-
PWY-8356
matairesinol biosynthesis
-
-
PWY-5466
melatonin degradation I
-
-
PWY-6398
melatonin degradation II
-
-
PWY-6399
melibiose degradation
-
-
PWY0-1301
Methanobacterium thermoautotrophicum biosynthetic metabolism
-
-
PWY-6146
methanofuran biosynthesis
-
-
PWY-5254
methanogenesis from H2 and CO2
-
-
METHANOGENESIS-PWY
methanol oxidation to formaldehyde IV
-
-
PWY-5506
methiin metabolism
-
-
PWY-7614
methoxylated aromatic compound degradation II
-
-
PWY-8305
methyl indole-3-acetate interconversion
-
-
PWY-6303
methyl ketone biosynthesis (engineered)
-
-
PWY-7007
methyl parathion degradation
-
-
PWY-5489
methyl phomopsenoate biosynthesis
-
-
PWY-7721
methyl tert-butyl ether degradation
-
-
PWY-7779
methyl-coenzyme M oxidation to CO2
-
-
PWY-5209
methylaspartate cycle
methylerythritol phosphate pathway I
-
-
NONMEVIPP-PWY
methylerythritol phosphate pathway II
-
-
PWY-7560
methylglyoxal degradation I
-
-
PWY-5386
methylglyoxal degradation III
-
-
PWY-5453
methylglyoxal degradation V
-
-
PWY-5458
methylglyoxal degradation VI
-
-
MGLDLCTANA-PWY
methylglyoxal degradation VIII
-
-
PWY-5386-1
methylsalicylate degradation
-
-
PWY18C3-24
mevalonate degradation
-
-
PWY-5074
mevalonate pathway I (eukaryotes and bacteria)
-
-
PWY-922
mevalonate pathway II (haloarchaea)
-
-
PWY-6174
mevalonate pathway III (Thermoplasma)
-
-
PWY-7524
mevalonate pathway IV (archaea)
-
-
PWY-8125
mineralocorticoid biosynthesis
-
-
PWY66-382
mitochondrial NADPH production (yeast)
-
-
PWY-7269
mixed acid fermentation
-
-
FERMENTATION-PWY
monoacylglycerol metabolism (yeast)
-
-
PWY-7420
mRNA capping I
-
-
PWY-7375
mucin core 1 and core 2 O-glycosylation
-
-
PWY-7433
mucin core 3 and core 4 O-glycosylation
-
-
PWY-7435
mupirocin biosynthesis
-
-
PWY-8012
muropeptide degradation
-
-
PWY0-1546
mycobactin biosynthesis
-
-
PWY185E-1
mycolyl-arabinogalactan-peptidoglycan complex biosynthesis
-
-
PWY-6397
myo-inositol biosynthesis
N-3-oxalyl-L-2,3-diaminopropanoate biosynthesis
-
-
PWY-8071
N-acetylneuraminate and N-acetylmannosamine degradation I
-
-
PWY0-1324
N-acetylneuraminate and N-acetylmannosamine degradation II
-
-
PWY-7581
NAD biosynthesis from 2-amino-3-carboxymuconate semialdehyde
-
-
PWY-5653
NAD de novo biosynthesis I
-
-
PYRIDNUCSYN-PWY
NAD de novo biosynthesis III
-
-
PWY-8352
NAD de novo biosynthesis IV (anaerobic)
-
-
PWY-8277
NAD phosphorylation and dephosphorylation
-
-
NADPHOS-DEPHOS-PWY
NAD phosphorylation and transhydrogenation
-
-
NADPHOS-DEPHOS-PWY-1
NAD salvage (plants)
-
-
PWY-5381
NAD salvage pathway I (PNC VI cycle)
-
-
PYRIDNUCSAL-PWY
NAD salvage pathway III (to nicotinamide riboside)
-
-
NAD-BIOSYNTHESIS-II
NAD salvage pathway IV (from nicotinamide riboside)
-
-
PWY3O-4106
NAD salvage pathway V (PNC V cycle)
-
-
PWY3O-4107
NAD(P)/NADPH interconversion
-
-
PWY-5083
NADH to cytochrome bd oxidase electron transfer I
-
-
PWY0-1334
NADH to cytochrome bo oxidase electron transfer I
-
-
PWY0-1335
NADH to fumarate electron transfer
-
-
PWY0-1336
NADP biosynthesis
-
-
PWY-8148
NADPH to cytochrome c oxidase via plastocyanin
-
-
PWY-8271
neolacto-series glycosphingolipids biosynthesis
-
-
PWY-7841
neolinustatin bioactivation
-
-
PWY-7092
nicotine biosynthesis
-
-
PWY-5316
nicotine degradation IV
-
-
PWY66-201
nicotine degradation V
-
-
PWY66-221
nitrate reduction I (denitrification)
-
-
DENITRIFICATION-PWY
nitrate reduction IX (dissimilatory)
-
-
PWY0-1581
nitrate reduction VII (denitrification)
-
-
PWY-6748
nitrate reduction X (dissimilatory, periplasmic)
-
-
PWY0-1584
nitric oxide biosynthesis II (mammals)
-
-
PWY-4983
nitrifier denitrification
-
-
PWY-7084
nitrite-dependent anaerobic methane oxidation
-
-
PWY-6523
nitrogen fixation I (ferredoxin)
-
-
N2FIX-PWY
nitrogen remobilization from senescing leaves
-
-
PWY-6549
nocardicin A biosynthesis
-
-
PWY-7797
noradrenaline and adrenaline degradation
-
-
PWY-6342
norspermidine biosynthesis
-
-
PWY-6562
nucleoside and nucleotide degradation (archaea)
-
-
PWY-5532
o-diquinones biosynthesis
-
-
PWY-6752
octane oxidation
octopamine biosynthesis
-
-
PWY-7297
odd iso-branched-chain fatty acid biosynthesis
-
-
PWY-8174
oleandomycin activation/inactivation
-
-
PWY-6972
oleate beta-oxidation
-
-
PWY0-1337
oleate beta-oxidation (isomerase-dependent, yeast)
-
-
PWY-7291
oleate biosynthesis II (animals and fungi)
-
-
PWY-5996
oleate biosynthesis III (cyanobacteria)
-
-
PWY-7587
oleoresin monoterpene volatiles biosynthesis
-
-
PWY-5423
ophthalmate biosynthesis
-
-
PWY-8043
palmitoleate biosynthesis III (cyanobacteria)
-
-
PWY-7589
palmitoleate biosynthesis IV (fungi and animals)
-
-
PWY3O-1801
palmitoyl ethanolamide biosynthesis
-
-
PWY-8055
paraoxon degradation
-
-
PWY-5490
parathion degradation
-
-
PARATHION-DEGRADATION-PWY
partial TCA cycle (obligate autotrophs)
-
-
PWY-5913
pederin biosynthesis
-
-
PWY-8049
pentachlorophenol degradation
-
-
PCPDEG-PWY
pentose phosphate pathway (non-oxidative branch) I
-
-
NONOXIPENT-PWY
pentose phosphate pathway (non-oxidative branch) II
-
-
PWY-8178
pentose phosphate pathway (oxidative branch) I
-
-
OXIDATIVEPENT-PWY
pentose phosphate pathway (partial)
-
-
P21-PWY
peptido-conjugates in tissue regeneration biosynthesis
-
-
PWY-8355
peptidoglycan biosynthesis II (staphylococci)
-
-
PWY-5265
peptidoglycan biosynthesis IV (Enterococcus faecium)
-
-
PWY-6471
peptidoglycan maturation (meso-diaminopimelate containing)
-
-
PWY0-1586
peptidoglycan recycling I
-
-
PWY0-1261
peptidoglycan recycling II
-
-
PWY-7883
phenylethanol biosynthesis
-
-
PWY-5751
phenylethylamine degradation I
-
-
2PHENDEG-PWY
pheomelanin biosynthesis
-
-
PWY-7917
phosphate acquisition
-
-
PWY-6348
phosphatidate biosynthesis (yeast)
-
-
PWY-7411
phosphatidate metabolism, as a signaling molecule
-
-
PWY-7039
phosphatidylcholine acyl editing
-
-
PWY-6803
phosphatidylcholine biosynthesis I
-
-
PWY3O-450
phosphatidylcholine biosynthesis II
-
-
PWY4FS-2
phosphatidylcholine biosynthesis V
-
-
PWY-6825
phosphatidylcholine biosynthesis VII
-
-
PWY-7470
phosphatidylcholine resynthesis via glycerophosphocholine
-
-
PWY-7367
phosphatidylethanolamine biosynthesis II
-
-
PWY4FS-6
phosphatidylethanolamine biosynthesis III
-
-
PWY-6273
phosphatidylglycerol biosynthesis I
-
-
PWY4FS-7
phosphatidylglycerol biosynthesis II
-
-
PWY4FS-8
phosphatidylinositol biosynthesis I (bacteria)
-
-
PWY-6580
phosphatidylserine and phosphatidylethanolamine biosynthesis I
-
-
PWY-5669
phosphatidylserine biosynthesis I
-
-
PWY-7501
phosphatidylserine biosynthesis II
-
-
PWY-7506
phospholipases
-
-
LIPASYN-PWY
phospholipid remodeling (phosphatidate, yeast)
-
-
PWY-7417
phospholipid remodeling (phosphatidylcholine, yeast)
-
-
PWY-7416
phospholipid remodeling (phosphatidylethanolamine, yeast)
-
-
PWY-7409
phosphopantothenate biosynthesis I
-
-
PANTO-PWY
photorespiration I
-
-
PWY-181
photorespiration II
-
-
PWY-8362
photorespiration III
-
-
PWY-8363
photosynthesis light reactions
-
-
PWY-101
photosynthetic 3-hydroxybutanoate biosynthesis (engineered)
-
-
PWY-7218
phytate degradation I
-
-
PWY-4702
phytol degradation
-
-
PWY66-389
phytosterol biosynthesis (plants)
-
-
PWY-2541
pinitol biosynthesis I
-
-
PWY-6738
plasmalogen biosynthesis I (aerobic)
-
-
PWY-7782
plasmalogen degradation
-
-
PWY-7783
plastoquinol-9 biosynthesis I
-
-
PWY-1581
platensimycin biosynthesis
-
-
PWY-8179
poly(3-O-beta-D-glucopyranosyl-N-acetylgalactosamine 1-phosphate) wall teichoic acid biosynthesis
-
-
PWY-7819
poly(glycerol phosphate) wall teichoic acid biosynthesis
-
-
TEICHOICACID-PWY
poly(ribitol phosphate) wall teichoic acid biosynthesis I (B. subtilis)
-
-
PWY-7815
poly(ribitol phosphate) wall teichoic acid biosynthesis II (S. aureus)
-
-
PWY-7816
poly-hydroxy fatty acids biosynthesis
-
-
PWY-6710
polyhydroxybutanoate biosynthesis
-
-
PWY1-3
porphyran degradation
-
-
PWY-6815
ppGpp metabolism
-
-
PPGPPMET-PWY
preQ0 biosynthesis
-
-
PWY-6703
procollagen hydroxylation and glycosylation
-
-
PWY-7894
propanethial S-oxide biosynthesis
-
-
PWY-5707
propanoate fermentation to 2-methylbutanoate
-
-
PWY-5109
propanoyl-CoA degradation II
-
-
PWY-7574
protectin biosynthesis
-
-
PWY-8357
protective electron sinks in the thylakoid membrane (PSII to PTOX)
-
-
PWY1YI0-7
protein N-glycosylation (Haloferax volcanii)
-
-
PWY-7661
protein N-glycosylation initial phase (eukaryotic)
-
-
MANNOSYL-CHITO-DOLICHOL-BIOSYNTHESIS
protein N-glycosylation processing phase (endoplasmic reticulum, yeast)
-
-
PWY-7918
protein N-glycosylation processing phase (plants and animals)
-
-
PWY-7919
protein NEDDylation
-
-
PWY-7899
protein O-mannosylation I (yeast)
-
-
PWY-7921
protein O-mannosylation II (mammals, core M1 and core M2)
-
-
PWY-7922
protein O-mannosylation III (mammals, core M3)
-
-
PWY-7979
protein O-[N-acetyl]-glucosylation
-
-
PWY-7437
protein S-nitrosylation and denitrosylation
-
-
PWY-7798
protein ubiquitination
-
-
PWY-7511
PRPP biosynthesis
-
-
PWY0-662
psilocybin biosynthesis
-
-
PWY-7936
purine deoxyribonucleosides degradation I
-
-
PWY-7179
purine deoxyribonucleosides degradation II
-
-
PWY-7179-1
purine deoxyribonucleosides salvage
-
-
PWY-7224
purine nucleobases degradation I (anaerobic)
-
-
P164-PWY
purine nucleobases degradation II (anaerobic)
-
-
PWY-5497
purine ribonucleosides degradation
-
-
PWY0-1296
putrescine biosynthesis I
-
-
PWY-40
putrescine biosynthesis II
-
-
PWY-43
putrescine biosynthesis III
-
-
PWY-46
putrescine degradation III
-
-
PWY-0
pyridoxal 5'-phosphate biosynthesis I
-
-
PYRIDOXSYN-PWY
pyridoxal 5'-phosphate salvage I
-
-
PLPSAL-PWY
pyridoxal 5'-phosphate salvage II (plants)
-
-
PWY-7204
pyrimidine deoxyribonucleosides degradation
-
-
PWY-7181
pyrimidine deoxyribonucleosides salvage
-
-
PWY-7199
pyrimidine deoxyribonucleotide phosphorylation
-
-
PWY-7197
pyrimidine deoxyribonucleotides biosynthesis from CTP
-
-
PWY-7210
pyrimidine deoxyribonucleotides de novo biosynthesis I
-
-
PWY-7184
pyrimidine deoxyribonucleotides de novo biosynthesis II
-
-
PWY-7187
pyrimidine deoxyribonucleotides de novo biosynthesis III
-
-
PWY-6545
pyrimidine deoxyribonucleotides de novo biosynthesis IV
-
-
PWY-7198
pyrimidine deoxyribonucleotides dephosphorylation
-
-
PWY-7206
pyrimidine ribonucleosides degradation
-
-
PWY0-1295
pyrimidine ribonucleosides salvage I
-
-
PWY-7193
pyrimidine ribonucleosides salvage II
-
-
PWY-6556
pyruvate decarboxylation to acetyl CoA I
-
-
PYRUVDEHYD-PWY
pyruvate decarboxylation to acetyl CoA II
-
-
PWY-6970
pyruvate fermentation to (R)-lactate
-
-
PWY-8274
pyruvate fermentation to (S)-lactate
-
-
PWY-5481
pyruvate fermentation to acetate II
-
-
PWY-5482
pyruvate fermentation to acetate V
-
-
PWY-5537
pyruvate fermentation to acetate VI
-
-
PWY-5538
pyruvate fermentation to acetate VIII
-
-
PWY-5768
pyruvate fermentation to acetoin III
-
-
PWY3O-440
pyruvate fermentation to acetone
-
-
PWY-6588
pyruvate fermentation to butanoate
-
-
CENTFERM-PWY
pyruvate fermentation to butanol I
-
-
PWY-6583
pyruvate fermentation to butanol II (engineered)
-
-
PWY-6883
pyruvate fermentation to ethanol I
-
-
PWY-5480
pyruvate fermentation to ethanol II
-
-
PWY-5486
pyruvate fermentation to ethanol III
-
-
PWY-6587
pyruvate fermentation to hexanol (engineered)
-
-
PWY-6863
pyruvate fermentation to isobutanol (engineered)
-
-
PWY-7111
pyruvate fermentation to propanoate I
-
-
P108-PWY
quercetin sulfate biosynthesis
-
-
PWY-6199
queuosine biosynthesis I (de novo)
-
-
PWY-6700
queuosine biosynthesis III (queuosine salvage)
-
-
PWY-8106
reactive oxygen species degradation
-
-
DETOX1-PWY-1
reductive acetyl coenzyme A pathway I (homoacetogenic bacteria)
-
-
CODH-PWY
reductive acetyl coenzyme A pathway II (autotrophic methanogens)
-
-
PWY-7784
reductive glycine pathway of autotrophic CO2 fixation
-
-
PWY-8303
reductive TCA cycle I
-
-
P23-PWY
reductive TCA cycle II
-
-
PWY-5392
resolvin D biosynthesis
-
-
PWY66-397
retinol biosynthesis
-
-
PWY-6857
ribitol degradation I
-
-
RIBITOLUTIL-PWY
ribose phosphorylation
-
-
RIBOKIN-PWY
ricinoleate biosynthesis
-
-
PWY-7618
rosmarinic acid biosynthesis I
-
-
PWY-5048
rosmarinic acid biosynthesis II
-
-
PWY-5049
rubber biosynthesis
-
-
PWY-5815
Rubisco shunt
-
-
PWY-5723
S-(6-hydroxy-4-methylhexan-4-yl)-L-cysteinylglycine biosynthesis
-
-
PWY-8301
S-adenosyl-L-methionine biosynthesis
-
-
SAM-PWY
S-adenosyl-L-methionine salvage I
-
-
PWY-6151
S-adenosyl-L-methionine salvage II
-
-
PWY-5041
S-methyl-5'-thioadenosine degradation II
-
-
PWY-6756
salicylate biosynthesis I
-
-
PWY-6406
salicylate biosynthesis II
-
-
PWY-8321
salidroside biosynthesis
-
-
PWY-6802
salinosporamide A biosynthesis
-
-
PWY-6627
Salmonella enterica serotype O:13 O antigen biosynthesis
-
-
PWY-8230
Salmonella enterica serotype O:54 O antigen biosynthesis
-
-
PWY-8204
saponin biosynthesis II
-
-
PWY-5756
secologanin and strictosidine biosynthesis
-
-
PWY-5290
sedoheptulose bisphosphate bypass
-
-
PWY0-1517
selenate reduction
-
-
PWY-6932
seleno-amino acid biosynthesis (plants)
-
-
PWY-6936
seleno-amino acid detoxification and volatilization I
-
-
PWY-6931
seleno-amino acid detoxification and volatilization III
-
-
PWY-6933
serotonin and melatonin biosynthesis
-
-
PWY-6030
serotonin degradation
-
-
PWY-6313
sesamin biosynthesis
-
-
PWY-5469
sitosterol degradation to androstenedione
-
-
PWY-6948
sorgoleone biosynthesis
-
-
PWY-5987
spermidine biosynthesis I
-
-
BSUBPOLYAMSYN-PWY
spermidine biosynthesis II
-
-
PWY-6559
spermidine biosynthesis III
-
-
PWY-6834
spermine and spermidine degradation I
-
-
PWY-6117
spermine and spermidine degradation III
-
-
PWY-6441
spermine biosynthesis
-
-
ARGSPECAT-PWY
sphingolipid biosynthesis (mammals)
-
-
PWY-7277
sphingolipid biosynthesis (plants)
-
-
PWY-5129
sphingolipid biosynthesis (yeast)
-
-
SPHINGOLIPID-SYN-PWY
sphingomyelin metabolism
-
-
PWY3DJ-11281
sphingosine and sphingosine-1-phosphate metabolism
-
-
PWY3DJ-11470
Spodoptera littoralis pheromone biosynthesis
-
-
PWY-7656
sporopollenin precursors biosynthesis
-
-
PWY-6733
stachyose degradation
-
-
PWY-6527
starch biosynthesis
-
-
PWY-622
starch degradation I
-
-
PWY-842
starch degradation II
-
-
PWY-6724
starch degradation III
-
-
PWY-6731
starch degradation IV
-
-
PWY-6735
starch degradation V
-
-
PWY-6737
stearate biosynthesis I (animals)
-
-
PWY-5972
stearate biosynthesis III (fungi)
-
-
PWY3O-355
stellatic acid biosynthesis
-
-
PWY-7736
sterol biosynthesis (methylotrophs)
-
-
PWY-8026
sterol:steryl ester interconversion (yeast)
-
-
PWY-7424
stigma estolide biosynthesis
-
-
PWY-6453
streptomycin biosynthesis
-
-
PWY-5940
suberin monomers biosynthesis
-
-
PWY-1121
succinate to chytochrome c oxidase via cytochrome c6
-
-
PWY1YI0-2
succinate to cytochrome bd oxidase electron transfer
-
-
PWY0-1353
succinate to cytochrome bo oxidase electron transfer
-
-
PWY0-1329
succinate to cytochrome c oxidase via plastocyanin
-
-
PWY1YI0-3
succinate to plastoquinol oxidase
-
-
PWY1YI0-8
sucrose biosynthesis I (from photosynthesis)
-
-
SUCSYN-PWY
sucrose biosynthesis II
-
-
PWY-7238
sucrose biosynthesis III
-
-
PWY-7347
sucrose degradation I (sucrose phosphotransferase)
-
-
SUCUTIL-PWY
sucrose degradation II (sucrose synthase)
-
-
PWY-3801
sucrose degradation III (sucrose invertase)
-
-
PWY-621
sucrose degradation IV (sucrose phosphorylase)
-
-
PWY-5384
sucrose degradation V (sucrose alpha-glucosidase)
-
-
PWY66-373
sucrose degradation VII (sucrose 3-dehydrogenase)
-
-
SUCROSEUTIL2-PWY
sulfate activation for sulfonation
-
-
PWY-5340
sulfide oxidation IV (mitochondria)
-
-
PWY-7927
sulfite oxidation II
-
-
PWY-5279
sulfite oxidation III
-
-
PWY-5278
sulfolactate degradation III
-
-
PWY-6638
sulfur volatiles biosynthesis
-
-
PWY-6736
superoxide radicals degradation
-
-
DETOX1-PWY
superpathway of (Kdo)2-lipid A biosynthesis
-
-
KDO-NAGLIPASYN-PWY
superpathway of 5-aminoimidazole ribonucleotide biosynthesis
-
-
PWY-6277
superpathway of fermentation (Chlamydomonas reinhardtii)
-
-
PWY4LZ-257
superpathway of glucose and xylose degradation
-
-
PWY-6901
superpathway of glycolysis and the Entner-Doudoroff pathway
-
-
GLYCOLYSIS-E-D
superpathway of glycolysis, pyruvate dehydrogenase, TCA, and glyoxylate bypass
-
-
GLYCOLYSIS-TCA-GLYOX-BYPASS
superpathway of glyoxylate cycle and fatty acid degradation
-
-
PWY-561
superpathway of L-aspartate and L-asparagine biosynthesis
-
-
ASPASN-PWY
superpathway of methylsalicylate metabolism
-
-
PWY18C3-25
superpathway of nicotine biosynthesis
-
-
PWY-7342
superpathway of ornithine degradation
-
-
ORNDEG-PWY
superpathway of phospholipid biosynthesis II (plants)
-
-
PHOSLIPSYN2-PWY
superpathway of photosynthetic hydrogen production
-
-
PWY-7731
superpathway of pyrimidine deoxyribonucleotides de novo biosynthesis (E. coli)
-
-
PWY0-166
superpathway of UDP-glucose-derived O-antigen building blocks biosynthesis
-
-
PWY-7328
taurine biosynthesis I
-
-
PWY-5331
taurine biosynthesis II
-
-
PWY-7850
taurine biosynthesis III
-
-
PWY-8359
TCA cycle I (prokaryotic)
-
-
TCA
TCA cycle II (plants and fungi)
-
-
PWY-5690
TCA cycle III (animals)
-
-
PWY66-398
TCA cycle IV (2-oxoglutarate decarboxylase)
-
-
P105-PWY
TCA cycle V (2-oxoglutarate synthase)
-
-
PWY-6969
TCA cycle VI (Helicobacter)
-
-
REDCITCYC
TCA cycle VII (acetate-producers)
-
-
PWY-7254
TCA cycle VIII (Chlamydia)
-
-
TCA-1
tea aroma glycosidic precursor bioactivation
-
-
PWY-7114
teichuronic acid biosynthesis (B. subtilis 168)
-
-
PWY-7820
terminal O-glycans residues modification (via type 2 precursor disaccharide)
-
-
PWY-7434
testosterone and androsterone degradation to androstendione (aerobic)
-
-
PWY-6943
tetrahydrofolate biosynthesis I
-
-
PWY-6614
tetrahydrofolate biosynthesis II
-
-
PWY2DNV-11
tetrahydrofolate salvage from 5,10-methenyltetrahydrofolate
-
-
PWY-6613
tetrahydromonapterin biosynthesis
-
-
PWY0-1433
tetrapyrrole biosynthesis I (from glutamate)
-
-
PWY-5188
tetrapyrrole biosynthesis II (from glycine)
-
-
PWY-5189
theobromine biosynthesis I
-
-
PWY-5039
theophylline degradation
-
-
PWY-6999
thiazole component of thiamine diphosphate biosynthesis I
-
-
PWY-6892
thiazole component of thiamine diphosphate biosynthesis II
-
-
PWY-6891
thioredoxin pathway
-
-
THIOREDOX-PWY
thiosulfate disproportionation IV (rhodanese)
-
-
PWY-5350
threo-tetrahydrobiopterin biosynthesis
-
-
PWY-6983
thymine degradation
-
-
PWY-6430
thyroid hormone biosynthesis
thyroid hormone metabolism I (via deiodination)
-
-
PWY-6260
thyroid hormone metabolism II (via conjugation and/or degradation)
-
-
PWY-6261
toluene degradation II (aerobic) (via 4-methylcatechol)
-
-
TOLUENE-DEG-3-OH-PWY
toluene degradation to 2-hydroxypentadienoate (via toluene-cis-diol)
-
-
TOLUENE-DEG-DIOL-PWY
toluene degradation to 2-hydroxypentadienoate I (via o-cresol)
-
-
TOLUENE-DEG-2-OH-PWY
trans, trans-farnesyl diphosphate biosynthesis
-
-
PWY-5123
trans-4-hydroxy-L-proline degradation I
-
-
HYDROXYPRODEG-PWY
traumatin and (Z)-3-hexen-1-yl acetate biosynthesis
-
-
PWY-5410
trehalose biosynthesis IV
-
-
PWY-2622
trehalose degradation I (low osmolarity)
-
-
TREDEGLOW-PWY
trehalose degradation II (cytosolic)
-
-
PWY0-1182
trehalose degradation IV
-
-
PWY-2722
trehalose degradation V
-
-
PWY-2723
triacylglycerol degradation
-
-
LIPAS-PWY
tRNA charging
-
-
TRNA-CHARGING-PWY
tRNA processing
-
-
PWY0-1479
tunicamycin biosynthesis
-
-
PWY-7821
type I lipoteichoic acid biosynthesis (S. aureus)
-
-
PWY-7817
type IV lipoteichoic acid biosynthesis (S. pneumoniae)
-
-
PWY-7818
UDP-alpha-D-galactose biosynthesis
-
-
PWY-7344
UDP-alpha-D-glucose biosynthesis
-
-
PWY-7343
UDP-alpha-D-glucuronate biosynthesis (from UDP-glucose)
-
-
PWY-7346
UDP-N-acetyl-alpha-D-mannosaminouronate biosynthesis
-
-
PWY-7335
UDP-N-acetyl-D-galactosamine biosynthesis I
-
-
PWY-5512
UDP-N-acetyl-D-galactosamine biosynthesis II
-
-
PWY-5514
UDP-N-acetyl-D-galactosamine biosynthesis III
-
-
PWY-8013
UDP-N-acetyl-D-glucosamine biosynthesis I
-
-
UDPNAGSYN-PWY
UDP-N-acetyl-D-glucosamine biosynthesis II
-
-
UDPNACETYLGALSYN-PWY
UMP biosynthesis I
-
-
PWY-5686
UMP biosynthesis II
-
-
PWY-7790
UMP biosynthesis III
-
-
PWY-7791
uracil degradation I (reductive)
-
-
PWY-3982
urate conversion to allantoin I
-
-
PWY-5691
urate conversion to allantoin II
-
-
PWY-7394
urate conversion to allantoin III
-
-
PWY-7849
urea cycle
UTP and CTP de novo biosynthesis
-
-
PWY-7176
UTP and CTP dephosphorylation I
-
-
PWY-7185
UTP and CTP dephosphorylation II
-
-
PWY-7177
valproate beta-oxidation
-
-
PWY-8182
vancomycin resistance I
-
-
PWY-6454
vanillin biosynthesis I
-
-
PWY-5665
vitamin E biosynthesis (tocopherols)
-
-
PWY-1422
vitamin K-epoxide cycle
wax esters biosynthesis I
-
-
PWY-5884
xanthine and xanthosine salvage
-
-
SALVPURINE2-PWY
xanthommatin biosynthesis
-
-
PWY-8249
xyloglucan degradation II (exoglucanase)
-
-
PWY-6807
zymosterol biosynthesis
-
-
PWY-6074
bile acid biosynthesis, neutral pathway
-
-
PWY-6061
catecholamine biosynthesis
-
-
PWY66-301
cyanate degradation
-
-
CYANCAT-PWY
dolichol and dolichyl phosphate biosynthesis
-
-
PWY-6129
folate polyglutamylation
-
-
PWY-2161
methylaspartate cycle
-
-
PWY-6728
myo-inositol biosynthesis
-
-
PWY-2301
octane oxidation
-
-
P221-PWY
thyroid hormone biosynthesis
-
-
PWY-6241
urea cycle
-
-
PWY-4984
vitamin K-epoxide cycle
-
-
PWY-7999
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
ORGANISM
COMMENTARY
LITERATURE
UNIPROT
SEQUENCE DB
SOURCE
-
32, 378, 489, 1009, 1059, 1068, 1076, 1161, 1327, 1617, 2410, 3807, 3873, 3898, 4772, 4782, 4785, 37498, 81087, 134330, 134573, 134923, 135492, 171184, 210262, 210390, 210545, 285556, 347910, 347960, 349721, 392209, 392280, 438281, 438284, 438288, 441420, 441434, 441440, 441442, 485185, 485187, 486677, 486690, 486693, 486703, 487165, 487265, 487844, 488370, 489424, 489584, 489677, 489680, 489754, 638081, 638133, 638214, 638279, 638584, 639513, 639522, 640384, 640925, 641707, 642552, 644085, 645224, 645359, 645360, 645361, 645364, 645366, 645367, 645372, 646096, 646175, 647266, 650785, 651938, 652046, 652182, 652831, 654199, 654824, 655170, 655171, 656763, 657538, 657664, 657736, 657759, 657818, 657931, 658109, 658179, 658602, 658867, 659264, 659295, 659435, 659671, 659677, 659809, 659868, 660724, 660964, 661759, 662129, 662314, 663319, 663821, 664839, 665471, 666402, 667156, 667439, 667464, 667507, 667548, 667549, 667767, 668189, 668867, 669269, 669596, 672113, 673891, 673908, 673918, 673939, 674216, 674357, 674755, 675520, 675939, 677869, 678381, 679122, 679134, 679659, 680743, 680820, 681028, 681690, 681759, 683431, 685092, 686581, 686723, 690179, 690700, 690796, 690815, 691628, 692520, 692643, 693164, 693727, 694198, 694299, 695074, 696131, 696241, 696401, 696532, 696881, 697229, 697269, 700401, 701888, 701896, 702124, 702411, 702647, 702784, 703322, 703986, 704403, 704420, 704687, 704708, 706459, 706832, 707055, 707273, 707551, 711091, 711303, 711352, 711533, 714966, 719909, 719932, 719969, 720146, 721712, 722180, 723136, 724442, 731661, 732728, 733268, 734226, 734249, 734729, 735261, 736405, 740351, 744547, 745311, 751182, 753060, 754030, 763641
-
-
-
490962, 491457, 491924, 659141, 660974, 661228, 675791, 675952, 693711, 697262, 717758, 717759, 717761, 717762, 717768, 737388
SwissProt
-
Uniprot
1 difference to published sequence U65791: C1340 is A1340
SwissProt
chinese hamster
5727, 36724, 134285, 210382, 210501, 210515, 210546, 210550, 210569, 210572, 210588, 210589, 348016, 392398, 394854, 485718, 488106, 488111, 488113, 488114, 641110, 641111, 653117, 705494
-
-
chinese hamster, methotrexate-sensitive and methotrexate-resistant cells
-
-
genetically corrected revertant strain LY-B/cLCB1 of deficient mutant LY-B
-
-
male Syrian golden hamsters infected with different strains of Pseudomonas aeruginosa
-
-
tumor necrosis factor-alpha-converting enzyme mutant variant M1
SwissProt
tumor necrosis factor-alpha-converting enzyme mutant variant M2a
SwissProt
tumor necrosis factor-alpha-converting enzyme mutant variant M2b
SwissProt
two subunits of SPT, Sptlc1 and Sptlc2, i.e. LCB1 and LCB2 or SPT1 and SPT2
-
-
under native conditions the enzyme may be aggregated with beta-hexosaminidase, beta-galactosidase and alpha-fucosidase
-
-
wild-type and glycosylation mutant LEC29.Lec32, the mutation resides in either the structural gene encoding CMP-NeuAc synthetase or in a gene that regulates the prpduction of the active enzyme
-
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
SOURCE TISSUE
ORGANISM
UNIPROT
COMMENTARY
LITERATURE
SOURCE
-
range of enzyme activity differs up to 4fold among mink, mice, chinese hamster, rat and guinea pig
-
morphologically macrophage-like cells cloned from bone marrow cells by coculturing bone marrow cells with chondrocytes, the CCP-2 cells are similar to osteoclast but not the same
-
selected from spontaneously transformed Chinese hamster lung fibroblast DC-3F on the basis of resistance to actinomycin D
-
Lec15.1 cell have a single point mutation within the coding region of DPM2 gene. The cDNA of the mutant DPM2 subunit is expressed at a drastically reduced amount of DPM2 protein
-
peroxisome/plasmalogen-deficient variant of the CHO-K1 cell line
additional information
-
strong expression of isozyme CHCR1, weaker expression of isozyme CHCR2, no expression of isozyme CHCR3
-
81087, 347910, 437919, 441440, 441442, 486693, 486703, 487265, 638214, 638279, 641111, 642938, 644299, 645224, 645275, 645359, 645360, 645364, 645366, 645367, 645941, 646175, 654199, 654824, 655170, 655171, 658109, 658867, 659141, 659435, 659868, 660724, 661228, 661759, 662129, 663319, 665471, 666402, 667767, 669269, 674216, 675520, 675791, 675952, 677869, 679659, 681690, 685092, 686581, 690700, 690796, 690815, 691628, 692520, 693164, 694198, 695074, 696131, 696532, 696881, 697229, 700401, 701888, 702411, 702784, 703322, 703986, 710345, 711091, 711303, 711533, 717758, 717761, 719932, 720146, 721384, 721712, 722180, 723136, 724442, 731661, 733268, 734729, 735261, 736218, 744547, 744775, 745300, 753046, 753060, 753061
-
fucosylation-deficient Lec13 chinese hamster ovary cells have wild-type levels of Pofut1 and cell surface Notch receptors
-
generation of a stable CHO cell line with significantly reduced levels of CMP-Neu5Ac hydroxylase activity and reduced amounts of N-glycolylneuraminic acid, using a rational antisense RNA strategy
-
inhibition of caspase-8 enhances the viability of the CHO cells in both batch and fed-batch suspension cultures. Caspase-8 is possible involved in the apoptotic cell death in batch and fed-batch cultures of CHO cells
-
inhibition of caspase-9 enhances the viability of the CHO cells in both batch and fed-batch suspension cultures. Caspase-9 is possible involved in the apoptotic cell death in batch and fed-batch cultures of CHO cells
mutated sublines M1 and M2. M1 contains only one expressible TACE allele encoding an M435I point mutation in the catalytic center of the protease, and M2 cells produce two TACE variants with distinct point mutations in the catalytic domain (C22Y) and the cysteine-rich/disintegrin domain (C600Y)
-
stably expressing human imidazoline receptor antisera-selected protein IRAS
-
wild-type and PEX5-defective CHO cell lines each stable producing the enzyme
wild-type, Lec1 cells are deficient in enzyme activity, mutant Lec1A cells show weak enzyme activity, 2% compared to wild-type, and produce complex N-glycans
-
1161, 659264, 659671, 667507, 667548, 667549, 669596, 673891, 673918, 674357, 674755, 679122, 680820, 683431, 686581, 691628, 697262, 704403, 704687, 704708, 705470, 706459, 712170, 717759, 717762, 728311, 732728, 736405, 763641
chinese hamster ovary parental cell line (2.5fold induction of PGP synthase mRNA in response to N-acetylsphingosine-treatment, qRT-PCR) and etoposide-/N-acetylsphingosine-resistant cell line E91 (defect in ceramide signalling and RhoGAP activity, non-significant 1.2fold induction of PGP synthase mRNA in response to N-acetylsphingosine-treatment, qRT-PCR)
-
no activity due to molecular defect in endomannosidase, CHO cells have a W188C substitution, Trp188 is critical for Golgi localization and in vivo activity of endomannosidase
-
the cell shows very low enzyme activity due to deficiency of subunit LCB1
-
wild-type and mutant cell line deficient in phosphoribosyldiphosphate amidotransferase and phosphoribosyldiphosphate aminotransferase activities with normal activity of ribose-5-phosphate aminotransferase activities
-
range of enzyme activity differs up to 6fold among mink, mice, chinese hamster, rat and guinea pig
high expression of CHCR1 at both the mRNA and protein levels
high expression of CHCR2 at both the mRNA and protein levels
-
range of enzyme activity differs up to 500fold among mink, mice, chinese hamster, rat and guinea pig. Mink shows the highest kidney enzyme activity, guinea pig the lowest
-
strong expression of all 3 isozyme in descending order CHCR1, CHCR2, CHCR3
-
moderate expression of all 3 isozyme in descending order CHCR1, CHCR2, CHCR3
-
-
392, 416, 489, 1059, 1068, 1076, 1161, 1162, 4772, 4782, 4785, 5727, 36724, 134285, 134573, 135492, 171184, 347910, 392077, 392128, 392257, 394854, 438281, 438288, 441420, 485718, 487844, 488106, 488111, 488113, 488114, 489584, 638279, 639513, 644982, 645372, 655170, 655171, 659295, 659671, 693727, 694299, 697262, 704708
-
cells express only a trace amount of phosphatidylethanolamine N-methyltransferase. Transfection of CHO cells, ovary cell line MT58, with PEMT2 cDNA behind the cytomegalovirus promoter result in a series of cell lines that overexpress PEMT2
-
ovary cell line MT58, with impaired CDP-choline pathway caused by a temperature-sensitive mutation in CTP:phosphocholine cytidyltransferase. PEMT2 expression fails to rescue the mutant cell line at 40°C because it does not maintain phosphatidylcholine levels required for cellular replication
-
wild type and epipodophyllotoxin-resistant line VpmR-5
high expression of CHCR1 at both the mRNA and protein levels
high expression of CHCR2 at both the mRNA and protein levels
additional information
CHCR1 is absent from uterus and ovary. CHCR1 shows a sex-dependent expression at the protein level
additional information
-
located at the secondary ossification site of hamster humerus
additional information
no enzyme activity in CHO-K1 ovary cells lacking or expressing galactosylceramide synthase. The expression of both the GalCer substrate and endogenous GM3/GM4S is not sufficient to induce GM4 expression in cultured cells
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
LOCALIZATION
ORGANISM
UNIPROT
COMMENTARY
GeneOntology No.
LITERATURE
SOURCE
-
-
DPM1, the catalytic subunit of dolichol-phosphate mannose synthase, is tethered to and stabilized on the endoplasmic reticulum membrane by the small membrane protein DPM3
-
normally a lysosomal glycoprotein, released by secretion and/or cell lysis
-
-
in CHO cells, CCTalpha is nucleoplasmic and colocalized with GFP-progerin in nuclear folds and invaginations
additional information
-
cytoplasm at the early stage of culture, indicating that DGKgamma is transported from the cytoplasm to the nucleus
-
LEI is concentrated around the nucleus. LEI/L-DNase II nuclear export is leptomycin B sensitive. The export is mediated by Crm1 receptor
-
major part, enzyme participates in a multienzyme complex, not as large and stable as the one from nucleus
-
-
the enzyme has multiple transmembrane spans and a critical cytosolic loop
-
the N-terminal is orientated to the lumenal side, the C-terminal is orienated to the cytosolic side
-
the enzyme localizes to a compact juxtanuclear reticulum and partially colocalizes with GM130, a cis-Golgi marker protein
-
441440, 488370, 638214, 639513, 650785, 667549, 674216, 675520, 695074, 696532, 703322, 706459, 721384
-
comparison of enzyme activity in membranes of COS-7 cells, HEK-293 cells, SK-N-MC cells, CHO-K1 cells and MDBK cells. Comparatively, CHO-K1 cells display the highest level of enzyme. In all cell types, the enzyme predominates over aminopeptidase N
-
enzyme has a cytosolic part and a stem region which is very suceptible to proteolysis
-
functional reconstitution of sphingomyelin synthase in Chinese hamster ovary cell membranes
PSS2 of CHO-K1 cells is present only in mitochondria-associated membranes
-
the enzyme is mainly localized in the membrane of PEX5-defective mutant cells
-
the larger form of ACE2 is a type I membrane-anchored protein with a catalytically active ectodomain, that undergoes shedding resulting in the smaller soluble enzyme form
-
PSS2 of CHO-K1 cells is present only in mitochondria-associated membranes
-
0.4% of total activity in the cell, enzyme participates in a large and stable multienzyme complex
-
1.3% of total activity in the cell, enzyme participates in a large and stable multienzyme complex
-
2.4% of total activity in the cell, enzyme participates in a large and stable multienzyme complex
-
2.9% of total activity in the cell, enzyme participates in a large and stable multienzyme complex
-
3.1% of total enzyme amount in the cell, enzyme participates in a large and stable multienzyme complex
-
agonist-induced activity of nuclear DGKthata activity, nuclear localization of DGKdelta
-
lipid activation of the enzyme results in its translocation to the nuclear envelope and expansion of an intranuclear membrane network termed the nucleoplasmic reticulum by a mechanism involving membrane deformation
-
the enzyme is mainly localized in the peroxisomal matrix of wild-type cells
-
the Walker A1 motif of Pex1p is essential for Pex1p-pex6p interaction and Pex1p targeting to peroxisomes
-
cell cycle control protein CDC50A associates with and recruits P4-ATPase ATP8A1 to the plasma membrane
-
constitutively associated with phospholipid membranes
-
intimate association of both Pgp and its substrates with the membrane, dependence of the rate of tetramethylrosamine transport by Pgp on the bilayer phase state, the transport rate is relatively high in the rigid gel phase, reaches a maximum at the melting temperature of the bilayer, and then decreases in the fluid liquid crystalline phase
-
sphingomyelin regulates the activity of secretory phospholipase A2 in the plasma membrane
additional information
-
CERK can respond to stimuli by changing its localization, e.g. from Golgi to plasma membrane upon osmotic swelling, explaining perhaps the conflicting subcellular findings
-
additional information
-
cholesterol flux into and out of the endoplasmic reticulum
-
additional information
folylpoly-gamma-glutamate synthetase resides in both the cytoplasm and mitochondria
-
additional information
-
immunohistochemic analysis of enzyme subcellular localization, overview
-
additional information
two mRNAs for the fpgs gene direct isoforms of FPGS to the cytosol and to mitochondria
-
additional information
two mRNAs for the fpgs gene direct isoforms of FPGS to the cytosol and to mitochondria in mouse and human tissues
-
LINKS TO OTHER DATABASES (specific for Cricetulus griseus)
SILVA: 16S/18S rRNA, 23S/28S rRNA
Use of this online version of BRENDA is free under the CC BY 4.0 license. See terms of use for full details.
Release 2023.1 (January 2023)
Legal
Curated at
Member of
